NCT05855525 Real-time fMRI for Insular Cortex Brain State-triggered Experience Sampling
| NCT ID | NCT05855525 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Drexel University |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-02-15 |
| Primary Completion | 2025-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-02-15 with a primary completion date of 2025-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In a neuroimaging session, study participants will repeatedly and intermittently report the content of their ongoing, self-generated experiences based on an experience-sampling protocol in which self-report ratings will be triggered based on real-time analysis of the participant's current brain state. The protocol will be conducted while participants are undergoing MRI scanning.
Eligibility Criteria
Inclusion Criteria: * Age between 18-35 Exclusion Criteria: * History of psychiatric or neurological disorder * contraindication for MRI
Contact & Investigator
Aaron Kucyi, PhD
PRINCIPAL INVESTIGATOR
Drexel University
Frequently Asked Questions
Who can join the NCT05855525 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05855525 currently recruiting?
Yes, NCT05855525 is actively recruiting participants. Contact the research team at tb3344@drexel.edu for enrollment information.
Where is the NCT05855525 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT05855525 clinical trial?
NCT05855525 is sponsored by Drexel University. The principal investigator is Aaron Kucyi, PhD at Drexel University. The trial plans to enroll 60 participants.